UNDERSTANDING RSV RISKS IN ADULTS 50 YEARS AND OLDER

“Encouraging conversations around the risk of RSV in adults aged 75 years and older, or 50-74 years old with underlying conditions will help increase their understanding and awareness.”

–Dr. Len, VP and Director, Scientific Affairs and Public Health, Vaccines at GSK

Dr. Len doesn’t want you to be sidelined from the activities you love because of respiratory syncytial virus (RSV). Watch as he shares important facts so you can understand your risks for potentially severe RSV infection.

  • View Transcript

    DR. LEN FRIEDLAND: “My health is a top priority.”

    TEXT ON SCREEN:
    DR. LEN

    DR. FRIEDLAND: “I’m a physician and I’m also age 63,”

    TEXT ON SCREEN:
    DR. LEN FRIEDLAND, GSK

    DR. FRIEDLAND: “and I’m absolutely passionate about not only educating myself, but also educating others about the risks that potentially come as we age. And one of those risks is RSV.”

    TEXT ON SCREEN:
    RSV RESPIRATORY SYNCYTIAL VIRUS

    DR. FRIEDLAND: “RSV is a common contagious respiratory virus that affects people of all ages. Older adults and adults with chronic heart or lung disease, such as COPD, asthma, or chronic heart failure are at increased risk for severe RSV infection.”

    TEXT ON SCREEN:
    COPD CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    DR. FRIEDLAND: “And, each year in the United States, approximately 177,000 adults 65 and older are hospitalized due to RSV, and of these cases, an estimated 14,000 result in death. I don’t know about you, but I don’t want RSV to sideline me from doing this...”

    “or this…”

    “or this…”

    “99, 100.”

    “In fact, I don’t want RSV to sideline me from anything I like to do, and I don’t want it to sideline you either. Speak to your doctor or pharmacist about RSV risks and prevention. Vaccination may be an option for appropriate adults.”

    TEXT ON SCREEN:
    TALK TO YOUR DOCTOR OR PHARMACIST ABOUT RSV RISKS AND PREVENTION.

    VACCINATION MAY BE AN OPTION FOR APPROPRIATE ADULTS.

    Trademarks are owned by or licensed to the GSK group of companies.

    ©2024 GSK or licensor.
    PMUS-RVUVID240002 April 2024
    Produced in USA.

A headshot of Dr. Len Friedland

MEET DR. LEN

Dr. Leonard Friedland, Vice President, Director Scientific Affairs and Public Health at GSK Vaccines, is passionate about public health and raising awareness about infectious disease risk and preventative options including vaccines.

VACCINATION IS AVAILABLE TO HELP PROTECT ADULTS AGED 50-74 WITH CERTAIN
CHRONIC CONDITIONS AND ADULTS 75 AND OLDER AGAINST RSV. TALK TO YOUR
DOCTOR OR PHARMACIST AND SCHEDULE YOUR APPOINTMENT TODAY.